AB Science News and Activities
Presence
AB Science develops and sells pharmaceutical therapies for serious diseases. Its products and services include drug research, clinical development, and treatment programs for patients, hospitals, and healthcare providers.
AB Science products and services overview:
- Cancer therapies
- Inflammation treatments
- Neurology treatments
- Clinical development
- Drug research
Revenue: ~$2 million
Employees: 110
Headquarters: Paris, France
AB Science is one of the...
AB Science is a company listed under the stock ticker AB (FR).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at AB Science
- Alain Moussy, Chief Executive Officer and Director
- Brigitte Reverdin, Director
- Jean-Pierre Kinet, Director
Create your alert
to follow the executive moves at AB Science.
Pharmaceuticals
AB Science has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by AB Science
Social media about AB Science
- AB Science on Wikipedia, Google News & Yahoo Finance
- AB Science on LinkedIn, X (Twitter) & YouTube
